文献速递技术与安全介入CT

碘对比剂致过敏性休克的临床特征与危险因素

Clinical features and risk factors of iodinated contrast media (ICM)-induced anaphylaxis.
PubMed 文献 · Eur J Radiol · 2023-05-10

唯一与过敏性休克相关的因素是对比剂类型,以碘帕醇为参照,碘美普尔的OR为6.8(p<0.001)。

要点

  • 过敏性休克总体发生率极低,为每次给药0.06%、每例患者0.16%,均在给药后30分钟内起病。
  • 69%的过敏性休克病例无药物不良反应危险因素,其中31%曾使用过同一种致敏对比剂。
  • 以碘帕醇为参照,碘美普尔致过敏性休克的OR为6.8(p<0.001),年龄、性别及预用药的OR无显著差异。

核心结论

  • 碘对比剂所致过敏性休克总体发生率很低;超过半数病例无药物不良反应危险因素且既往使用对比剂无不良反应,但对比剂类型与较高的OR相关。

诊断标准与关键数值

  • 过敏性休克发生率为每次给药0.06%、每例患者0.16%,45例发生于45例不同患者,均在给药后30分钟内起病。
  • 以碘帕醇为参照,碘美普尔致过敏性休克的OR为6.8(p<0.001)。
  • 年龄、性别及预用药与过敏性休克的OR无显著差异。

临床应用与阅片要点

  • 过敏性休克均在给药后30分钟内起病,提示应关注该时段的不良反应监测。
  • 69%的过敏性休克病例无药物不良反应危险因素,其中31%曾使用过同一种致敏对比剂,31例(69%)既往使用对比剂无任何不良反应。
  • 4例(8.9%)接受了口服类固醇预用药。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To evaluate the clinical features and risk factors of iodinated contrast media (ICM)-induced anaphylaxis.

METHODS: This retrospective study included all patients undergoing contrast-enhanced computed tomography (CT) with intravenous ICM administration (iopamidol, iohexol, iomeprol, iopromide, ioversol) at our hospital between April 2016 and September 2021. Medical records of patients who experienced anaphylaxis were reviewed, and the multivariable regression model using generalized estimating equations was employed to eliminate the effect of intrapatient correlation.

RESULTS: Of the 76,194 ICM administrations (44,099 men [58 %] and 32,095 women; age, median, 68 years) to 27, 696 patients, anaphylaxis occurred in 45 cases in 45 different patients (0.06 % of administration and 0.16 % of patients), all with onset within 30 min after administration. Thirty-one (69 %) had no risk factors for ADRs, including 14 (31 %) who had previously used the same ICM that caused anaphylaxis. Thirty-one patients (69 %) had a history of ICM use without any ADRs. Four patients (8.9 %) received oral steroid premedication. The only factor associated with anaphylaxis was the type of ICM, with an odds ratio (OR) of 6.8 (p < 0.001) for iomeprol with iopamidol as a reference. No significant differences in OR of anaphylaxis were found for patients' age, sex, or premedication.

CONCLUSION: The overall incidence of anaphylaxis due to ICM was very low. More than half of the cases had no risk factors for ADRs and had no ADRs on past ICM administration, although the ICM type was associated with a higher OR.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Fukushima, Taketomi-Takahashi, Suto, et al. Clinical features and risk factors of iodinated contrast media (ICM)-induced anaphylaxis. Eur J Radiol. 2023. PMID: 37187078. doi:10.1016/j.ejrad.2023.110880

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。